Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships. / Druedahl, Louise C.; Minssen, Timo; Price II, William Nicholson.
In: Vaccine, Vol. 39, No. 42, 08.10.2021, p. 6291 - 6295.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships
AU - Druedahl, Louise C.
AU - Minssen, Timo
AU - Price II, William Nicholson
PY - 2021/10/8
Y1 - 2021/10/8
N2 - This paper provides an empirical investigation into the types of partnerships that have emerged during the pandemic to develop COVID-19 vaccines and to identify relevant factors that characterize these partnerships. We provide legal and policy considerations to our results that suggest an opportunity for policymakers to help shift the collaborative landscape to increase the potential for knowledge-sharing, the development of fundamental insight, and the adequate production of resulting technological goods, both in this pandemic and the next. Volume 39, Issue 42, 8 October 2021, Pages 6291-6295
AB - This paper provides an empirical investigation into the types of partnerships that have emerged during the pandemic to develop COVID-19 vaccines and to identify relevant factors that characterize these partnerships. We provide legal and policy considerations to our results that suggest an opportunity for policymakers to help shift the collaborative landscape to increase the potential for knowledge-sharing, the development of fundamental insight, and the adequate production of resulting technological goods, both in this pandemic and the next. Volume 39, Issue 42, 8 October 2021, Pages 6291-6295
KW - Faculty of Law
KW - Legal considerations
KW - Pharmaceutical policy
KW - COVID-19
KW - Vaccine
KW - knowledge sharing
KW - empirical legal studies
KW - empirical research
U2 - 10.1016/j.vaccine.2021.08.101
DO - 10.1016/j.vaccine.2021.08.101
M3 - Journal article
C2 - 34556366
VL - 39
SP - 6291
EP - 6295
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 42
ER -
ID: 276122727